Literature DB >> 11532328

Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications.

B Vanizor1, A Orem, S C Karahan, E Kiran, C Erem, R Aliyazicioğlu, H A Uydu.   

Abstract

Diabetes mellitus is associated with hyperglycaemia, hyperlipoproteinaemia, increased oxidative stress and decreased nitric oxide production from endothelial cells. In the present study the aim was to determine the relationships between serum lipids, lipoproteins, erythrocyte malondialdehyde (eMDA), as a marker for oxidative stress, and serum nitrite and nitrate levels, as degradation products of nitric oxide in type 2 diabetic patients without complications. The study group included 30 patients and 30 sex- and age-matched healthy volunteers. Total cholesterol, triacylglycerol, LDL cholesterol, apo B, HbA(1c) and glucose levels in patients were significantly higher than in controls, and HDL cholesterol levels lower. Increased eMDA levels and decreased nitrate and nitrite+nitrate levels (+/-SD) were observed in patients compared to controls (87+/-22 vs 59+/-17 nmol/g-Hb (P<0.01); 11.8+/-8.6 vs 22.8+/-10.8 micromol/l (P<0.01); and 16.8+/-11.0 vs 28.8+/-11.3 micromol/l (P<0.01), respectively). When the patients were divided into two groups according to HDL cholesterol levels (< or =0.91 and >0.91 mmol/l), total plasma nitric oxide end-products were found to be decreased in patients with low HDL levels compared to those patients with high HDL levels [men, 11.7+/-6.4 vs 24.6+/-14.9 micromol/l (P<0.01); women, 12.5+/-6.6 vs 21.4+/-6.6 micromol/l (P<0.01]. Nitrite and nitrate levels were correlated with HDL cholesterol (r=0.50, P<0.05) and eMDA (r=-0.52, P<0.05). It was concluded that the patients with unregulated blood glucose levels have abnormal lipid and lipoprotein metabolism and decreased nitric oxide end-products, with relationships between nitric oxide products and dyslipidaemia, especially between low HDL cholesterol levels and increased oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532328     DOI: 10.1016/s0168-8227(01)00281-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Dietary Inorganic Nitrate/Nitrite Supplementation Reduces Central and Peripheral Blood Pressure in Patients With Type 2 Diabetes Mellitus.

Authors:  Joshua M Bock; William E Hughes; Kenichi Ueda; Andrew J Feider; Satoshi Hanada; Darren P Casey
Journal:  Am J Hypertens       Date:  2022-09-01       Impact factor: 3.080

2.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

3.  The relationship of oxidative stress and cholesterol with dipping status before and after aerobic exercise training.

Authors:  Kathleen M Sturgeon; Nicola M Fenty-Stewart; Keith M Diaz; Tina E Brinkley; Thomas C Dowling; Michael D Brown
Journal:  Blood Press       Date:  2009       Impact factor: 2.835

4.  Reduced nitrate level in individuals with hypertension and diabetes.

Authors:  Gazalla Ayub Shiekh; Taha Ayub; Saquib Naveed Khan; Rubiya Dar; Khurshid Iqbal Andrabi
Journal:  J Cardiovasc Dis Res       Date:  2011-07

5.  Study of Lipid Peroxidation, Nitric Oxide End Product, and Trace Element Status in Type 2 Diabetes Mellitus with and without Complications.

Authors:  Sanjukta Mishra; Bana Bihari Mishra
Journal:  Int J Appl Basic Med Res       Date:  2017 Apr-Jun

6.  Lipopolysaccharide inhibits hepatic gluconeogenesis in rats: The role of immune cells.

Authors:  Hiroshi Tanaka; Yoshikazu Nishikawa; Toru Fukushima; Ataru Taniguchi; Yoshihito Fujita; Kinsuke Tsuda; Nobuya Inagaki; Masaya Hosokawa
Journal:  J Diabetes Investig       Date:  2017-08-14       Impact factor: 4.232

Review 7.  Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy.

Authors:  Chadinee Thippakorn; Nalini Schaduangrat; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2018-03-26       Impact factor: 4.068

8.  Validation of two point-of-care tests against standard lab measures of NO in saliva and in serum.

Authors:  Ashwin Modi; Evangelia Morou-Bermudez; Jose Vergara; Rakesh P Patel; Alexandria Nichols; Kaumudi Joshipura
Journal:  Nitric Oxide       Date:  2017-01-30       Impact factor: 4.427

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.